These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 25382490)

  • 1. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
    Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
    Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The COMPASs Study: Community Preferences for Prostate cAncer Screening. Protocol for a quantitative preference study.
    Howard K; Salkeld GP; Mann GJ; Patel MI; Cunich M; Pignone MP
    BMJ Open; 2012; 2(1):e000587. PubMed ID: 22226686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Values and preferences of men for undergoing prostate-specific antigen screening for prostate cancer: a systematic review.
    Vernooij RWM; Lytvyn L; Pardo-Hernandez H; Albarqouni L; Canelo-Aybar C; Campbell K; Agoritsas T
    BMJ Open; 2018 Sep; 8(9):e025470. PubMed ID: 30185585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
    Sicsic J; Pelletier-Fleury N; Moumjid N
    Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical Maximizing-Minimizing Preferences Predict Responses to Information about Prostate-Specific Antigen Screening.
    Scherer LD; Kullgren JT; Caverly T; Scherer AM; Shaffer VA; Fagerlin A; Zikmund-Fisher BJ
    Med Decis Making; 2018 Aug; 38(6):708-718. PubMed ID: 29916784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Men's preferences for prostate cancer screening: a discrete choice experiment.
    de Bekker-Grob EW; Rose JM; Donkers B; Essink-Bot ML; Bangma CH; Steyerberg EW
    Br J Cancer; 2013 Feb; 108(3):533-41. PubMed ID: 23361056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of US and Australian men's values and preferences for PSA screening.
    Howard K; Brenner AT; Lewis C; Sheridan S; Crutchfield T; Hawley S; Nielsen ME; Pignone MP
    BMC Health Serv Res; 2013 Oct; 13():388. PubMed ID: 24093428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA testing for men at average risk of prostate cancer.
    Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
    Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
    Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The importance of patient preference in the decision to screen for prostate cancer. Prostate Patient Outcomes Research Team.
    Flood AB; Wennberg JE; Nease RF; Fowler FJ; Ding J; Hynes LM
    J Gen Intern Med; 1996 Jun; 11(6):342-9. PubMed ID: 8803740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
    Avery KN; Metcalfe C; Vedhara K; Lane JA; Davis M; Neal DE; Hamdy FC; Donovan JL; Blazeby JM
    Eur Urol; 2012 Oct; 62(4):649-55. PubMed ID: 22244151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of information on prostate cancer screening decision process: a discrete choice experiment.
    Charvin M; Launoy G; Berchi C
    BMC Health Serv Res; 2020 May; 20(1):467. PubMed ID: 32456702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Difference in willingness-to-pay for prostate cancer screening between ill-informed and well-informed men: a contingent valuation survey.
    Yasunaga H; Sugihara T; Imamura T
    Urology; 2011 Jun; 77(6):1325-9. PubMed ID: 21507471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy.
    Godtman RA; Pettersson C; Svensson L; Kohestani K; Stinesen Bratt K; Wallström J; Månsson M; Hellström M; Hugosson J
    Eur Urol Oncol; 2024 Jun; 7(3):553-562. PubMed ID: 37993370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of prostate cancer in aging males receiving PSA (prostate specific antigen) screening test (A campaign for celebration of Siriraj Established Day).
    Srinualnad S; Charoenkraikamol C; Toraksa S; Uiprasertkul M; Amornvesukit T; Taweemonkongsap T; Udompunturak S; Nualyong C; Tantiwong A
    J Med Assoc Thai; 2006 Jan; 89(1):37-42. PubMed ID: 16583579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
    Elstad EA; Sutkowi-Hemstreet A; Sheridan SL; Vu M; Harris R; Reyna VF; Rini C; Earp JA; Brewer NT
    Med Decis Making; 2015 May; 35(4):467-76. PubMed ID: 25637592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment.
    Sculpher M; Bryan S; Fry P; de Winter P; Payne H; Emberton M
    BMJ; 2004 Feb; 328(7436):382. PubMed ID: 14751919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.